Key result
AngioVac right-sided cardiac thrombus removal and Micra leadless pacemaker placement can be safely and effectively implemented in a critically ill patient dependent on ECMO.
Why the study?
ECMO requires large-bore catheters in major blood vessels that often preclude the use of other transcatheter therapies requiring large-bore access.
Case Report (n=1)
Demonstrates the feasibility and safety of performing large-bore transcatheter procedures (AngioVac and Micra leadless pacemaker) in patients actively dependent on ECMO.
The use of extracorporeal membrane oxygenation (ECMO) in critically ill patients has been on the rise in recent years. While ECMO has provided substantial benefit to patients who need cardiopulmonary support, its required use of large-bore catheters in major blood vessels often precludes the use of other transcatheter therapies. In this article, we demonstrate that two transcatheter procedures, AngioVac right-sided cardiac thrombus removal and Micra leadless pacemaker placement, both requiring large bore access, can both be safely and effectively implemented in patients who are dependent on ECMO to maintain cardiopulmonary function.
No takes yet. Share an insight, caveat, or question.
Morse et al. (2024) conducted a case report in Critically ill patient receiving extracorporeal membrane oxygenation (n=1). AngioVac right-sided cardiac thrombus removal and Micra leadless pacemaker placement was evaluated on Safety and efficacy of the procedures. AngioVac right-sided cardiac thrombus removal and Micra leadless pacemaker placement can be safely and effectively implemented in a critically ill patient dependent on ECMO.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: